Regelidine

CAS No. 114542-54-0

Regelidine( —— )

Catalog No. M22820 CAS No. 114542-54-0

Regelidine is a natural product from Tripterygium regelii.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 316 In Stock
10MG 473 In Stock
25MG 756 In Stock
50MG 1004 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Regelidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Regelidine is a natural product from Tripterygium regelii.
  • Description
    Regelidine is a natural product from Tripterygium regelii.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114542-54-0
  • Formula Weight
    599.7
  • Molecular Formula
    C35H37NO8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@@]12[C@@]3([C@@](O)(CC[C@@H]2OC(C4=CC=CC=C4)=O)C)[C@@]([H])([C@@](C(C)(C)O3)([H])C[C@@H]1OC(C5=CC=CC=C5)=O)OC(C6=CN=CC=C6)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fan, Dongsheng, Zhu, Guo-Yuan, Chen, Ming,et al. Dihydro-β-agarofuran sesquiterpene polyesters isolated from the stems of Tripterygium regelii[J]. Fitoterapia, 2016, 112:1-8.
molnova catalog
related products
  • Cassiaside B

    Cassiaside is a naphthyl ketone glycoside that inhibits BACE1 (IC50= 4.45 μM; Ki=9.85 μM).Cassiaside exhibits significant hepatoprotective effects against galactosamine injury and has potential anti-Alzheimer's disease (AD) activity.

  • Debilon

    Debilon shows cytotoxic activity against P-388 cells.

  • ZED-1227

    ZED-1227 (TAK-227) is an orally active, selective and potent transglutaminase 2 (TG2) inhibitor with anticancer activity that blocks inflammation-induced TG2 expression and activation for the treatment of Celiac Disease.